Literature DB >> 17972223

Ocular surface disease index for the diagnosis of dry eye syndrome.

Fatih Ozcura1, Sayime Aydin, Mehmet Rami Helvaci.   

Abstract

PURPOSE: Evaluation of ocular surface disease index (OSDI) questionnaire for the diagnosis of dry eye syndrome.
METHODS: Sixty-eight patients admitted to the Ophthalmology Polyclinic of the Dumlupinar University between December 2005 and April 2006 were randomly studied. The OSDI questionnaire was performed before, and the Schirmer and tear film breakup time (TBUT) tests were performed after the routine ophthalmologic examination.
RESULTS: There was a significant inverse correlation between the OSDI and TBUT test scores, but no correlation between the Schirmer test scores and OSDI (r = -.296, p = .014, r = -.182, p = .138, respectively). Although there was a significant difference between the low and high OSDI having cases according to the TBUT test scores (p = .043), there was not according to the Schirmer test scores.
CONCLUSIONS: The OSDI is a standardized instrument to evaluate symptoms, and can easily be performed and used to support the diagnosis of dry eye syndrome.

Entities:  

Mesh:

Year:  2007        PMID: 17972223     DOI: 10.1080/09273940701486803

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  46 in total

1.  Central corneal thickness and corneal curvature in patients with rheumatoid arthritis.

Authors:  Fatih Özcura; Serdar Aktaş; Yasemin Özkan; Mehmet Tetikoğlu; Hacı Murat Sağdik
Journal:  Int Ophthalmol       Date:  2016-05-09       Impact factor: 2.031

2.  Perceptions of dry eye disease management in current clinical practice.

Authors:  Jennifer F Williamson; Kyle Huynh; Mark A Weaver; Richard M Davis
Journal:  Eye Contact Lens       Date:  2014-03       Impact factor: 2.018

3.  Assessment of corneal epithelial thickness in dry eye patients.

Authors:  Xinhan Cui; Jiaxu Hong; Fei Wang; Sophie X Deng; Yujing Yang; Xiaoyu Zhu; Dan Wu; Yujin Zhao; Jianjiang Xu
Journal:  Optom Vis Sci       Date:  2014-12       Impact factor: 1.973

4.  Evaluation of dry eye signs and symptoms in patients with systemic sclerosis.

Authors:  Beatriz de A F Gomes; Marcony R Santhiago; Mário N L de Azevedo; Haroldo V Moraes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-18       Impact factor: 3.117

5.  Contact lens to measure individual ion concentrations in tears and applications to dry eye disease.

Authors:  Ramachandram Badugu; Bennie H Jeng; E Albert Reece; Joseph R Lakowicz
Journal:  Anal Biochem       Date:  2017-11-26       Impact factor: 3.365

6.  In vivo detection of clinically non-apparent ocular surface inflammation in patients with meibomian gland dysfunction-associated refractory dry eye symptoms: a pilot study.

Authors:  Y Qazi; A Kheirkhah; C Blackie; A Cruzat; M Trinidad; C Williams; D R Korb; P Hamrah
Journal:  Eye (Lond)       Date:  2015-06-19       Impact factor: 3.775

7.  Clusterin from human clinical tear samples: Positive correlation between tear concentration and Schirmer strip test results.

Authors:  Valerie Yu; Dhruva Bhattacharya; Andrew Webster; Aditi Bauskar; Charles Flowers; Martin Heur; Shravan K Chintala; Tatsuo Itakura; Mark R Wilson; Joseph T Barr; Shinwu Jeong; Mingwu Wang; M Elizabeth Fini
Journal:  Ocul Surf       Date:  2018-08-02       Impact factor: 5.033

8.  Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.

Authors:  Gregory Katz; Clark L Springs; E Randy Craven; Michela Montecchi-Palmer
Journal:  Clin Ophthalmol       Date:  2010-11-03

Review 9.  Autologous serum eye drops for dry eye.

Authors:  Qing Pan; Adla Angelina; Andrea Zambrano; Michael Marrone; Walter J Stark; Thomas Heflin; Li Tang; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2013-08-27

10.  Electrocoagulative surgical procedure for treatment of conjunctivochalasis.

Authors:  Xing-Ru Zhang; Zhen-Yong Zhang; Matthew R Hoffman
Journal:  Int Surg       Date:  2012 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.